Azadeh Reshadmanesh

Azadeh Reshadmanesh

Auto-generated profile, based on publicly available information

Azadeh Reshadmanesh

Department of Medical Biotechnology , Faculty of Medical Sciences , Tarbiat Modares University , Tehran , Iran , modares.ac.ir

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2024 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
ARAzadeh Reshadmanesh
Azadeh Reshadmanesh
SDShima Dehdahsi
Shima Dehdahsi
FAFatemeh Ahangari
Fatemeh Ahangari
KKKimia Kahrizi
Kimia Kahrizi
AKAriana Kariminejad
Ariana Kariminejad
HNHossein Najmabadi
Hossein Najmabadi
Here, we report a case with concomitant variants: a novel homozygous HERC1 gene variant and a novel heterozygous PMP22 duplication. The 2-year-old male presented with seizures, developmental delay, macrocephaly, hypotonia, unilateral hypertrophy, thoracic scoliosis, normal brain MRI, and elevated homocysteine level which normalized after treatment. Whole exome sequencing (WES) revealed a co-occurrence of a homozygous novel likely pathogenic variant in the HERC1 gene (NM_003922.3:c.1280dup (p.ILe469Aspfs*33) and a novel heterozygous large duplication of exon 1-5 in the PMP22 gene, which has not been reported previously. The case underscores the challenges in understanding genotype-phenotype correlations and suggests a potential interplay between these genetic variants in shaping the current and future clinical phenotype of the patient. In the case of genetic diseases, this event may have important implications on family members’ counseling, and concomitant variants in Charcot–Marie–Tooth (CMT) families should be considered when significant intra-familial clinical heterogeneity is observed.

1 January 2026 in Case Reports in Immunology
Verified
Journal Article
Open access
PDF file
MDMohammadreza Dolikhani
Mohammadreza Dolikhani
GSGhazaleh Shakibamaram
Ghazaleh Shakibamaram
PRParisa Rashtian
Parisa Rashtian
MSMohammad Saberi
Mohammad Saberi
ARAzadeh Reshadmanesh
Azadeh Reshadmanesh
JBJacinta Bustamante
Jacinta Bustamante
Background: Mendelian susceptibility to mycobacterial disease (MSMD) is a subset of inborn errors of immunity (IEIs) predisposing to clinical infections from less virulent mycobacterial species. Variants in 22 genes, particularly in IL‐12Rβ1, have been identified that impair interferon‐gamma (IFN‐γ)‐mediated immunity. We report a new rare MSMD patient with a homozygous IL12RB1 variant who presented with severe and persistent ascites. Case Report: We investigated a 30‐month‐old girl who developed an abscess and lymphadenopathy (LAP) in the left axilla after receiving a BCG vaccine. She was diagnosed and treated for BCG‐osis. She presented with ascites, which gradually worsened, along with symptoms of liver dysfunction. Her portal hypertension (PHT) was considered the most likely cause of ascites after exclusion of other common causes. The whole exome sequencing (WES) revealed a homozygous rare variant (c.635G>A; p.Arg212Gln) in the IL12RB1 gene. Sanger sequencing analysis confirmed that both parents were heterozygous carriers of the variant. She made a good recovery after receiving the appropriate antimycobacterial and ascites treatments, with significant resolution of her symptoms. Because disseminated M. bovis BCG infection occurred in the setting of IL‐12Rβ1 deficiency, prolonged susceptibility‐guided antimycobacterial therapy with adjunctive IFN‐γ1b and close follow‐up by infectious disease and immunology, was planned. Conclusion: This case highlights severe persistent ascites as an unusual manifestation of PHT in IL‐12Rβ1 deficiency associated with MSMD. Evaluation for PHT should be considered in MSMD patients with abdominal distension, gastrointestinal symptoms, hepatosplenomegaly, abnormal liver function tests, growth failure, or unexplained free abdominal fluid.

9 November 2025 in Immunopathologia Persa
Verified
Journal Article
Open access
PDF file
MSMohammad Saberi
Mohammad Saberi
MTMorteza Talebi
Morteza Talebi
AGAli Ghorbani
Ali Ghorbani
ARAzadeh Reshadmanesh
Azadeh Reshadmanesh
SSSamin Sharafian
Samin Sharafian
PPPaniz Pourpashang
Paniz Pourpashang
Schimke immuno-osseous dysplasia (SIOD) is an exceptionally rare autosomal recessive disorder that affects multiple organ systems, most notably the skeletal system, kidneys, and immune system. The clinical manifestations of SIOD include growth retardation, skeletal deformities, progressive proteinuria, and immunodeficiency. Severe cases may progress to nephrotic syndrome and cerebral infarctions. The disorder is primarily attributed to biallelic mutations in the SMARCAL1 gene, which leads to the early onset of symptoms and often results in premature mortality. In this study, we identified a novel gross deletion encompassing exons 5 and 6 of the SMARCAL1 gene. This deletion leads to a partial loss of the HARP1 and HARP2 domains and the generation of a novel HARP domain that is structurally similar to both HARP1 and HARP2, while retaining conserved amino acids. Our AlphaFold 3D modeling indicated that the truncated SMARCAL1 protein is identical to the wild-type SMARCAL1, except for the absence of HARP1 domain, and resembles invertebrate SMARCAL1, which naturally possesses only one HARP domain. Previous studies have demonstrated that human SMARCAL1 lacking the HARP1 domain retains normal helicase, ATPase, and DNA-binding activities. Additionally, invertebrate SMARCAL1, which also lacks the HARP1 domain, fails to effectively regress DNA replication forks. This suggests that the identified gross deletion may contribute to SIOD pathogenesis by impairing DNA replication fork regression and genomic instability

1 January 2026 in Case Reports in Immunology
Verified
Journal Article
Open access
PDF file
Hamidreza AshayeriHamidreza Ashayeri
Hamidreza Ashayeri
SEShabnam Eskandarzadeh
Shabnam Eskandarzadeh
SASamin Alavi
Samin Alavi
MSMohammad Saberi
Mohammad Saberi
ARAzadeh Reshadmanesh
Azadeh Reshadmanesh
Background: Serine/threonine kinase 4 (STK4) deficiency is one of the rare causes of combined immunodeficiency (CID). In this study, we report a novel mutation causing STK4 deficiency, which presents with chronic pyelonephritis, an uncommon presentation. Case Presentation: A 10‐year‐old female with an incidental mass in the kidney extending to the liver, night sweats, and fever was presented. To reduce the mass effect and rule out the possibility of malignancy, the patient underwent a nephrectomy, and a biopsy revealed chronic pyelonephritis. After surgery, due to the persistent leukopenia, the chance of an inborn error of immunity was considered. The patient was referred to the immunology clinic. Investigations: Immunophenotyping revealed low levels of CD3 and CD4. The antibody titer did not show a significant rise after receiving diphtheria and tetanus vaccines. Whole‐exome sequencing was performed, and a novel homozygous c.248del, p.Pro83Leufs   ∗ 3 variant was reported in the STK4 gene. The presence of this variant in parents was also confirmed with Sanger sequencing. Conclusion: STK4 deficiency is a rare cause of CID characterized by susceptibility to recurrent infections. Our case shows immune dysfunction manifested as a complex inflammatory syndrome, featuring an abdominal mass that mimics malignancy, expanding the recognized clinical spectrum of this condition.